VALYSTR · Stock research
Listed on NYSE. What the market is pricing into Emergent BioSolutions Inc. (EBS) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Drug Manufacturers - Specialty & Generic · market value about $320M · revenue $770M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows